Why Assuring the Quality of Antimicrobials Is a Global Imperative.
| Autor: | Cadwallader AB; Director of regulatory and public policy development at US Pharmacopeia., Nallathambi K; Senior advisor on policy and advocacy for Project Hope., Ching C; US Pharmacopeia Quality Institute fellow. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | AMA journal of ethics [AMA J Ethics] 2024 Jun 01; Vol. 26 (6), pp. E472-478. Date of Electronic Publication: 2024 Jun 01. |
| DOI: | 10.1001/amajethics.2024.472 |
| Abstrakt: | Poor-quality antimicrobial medicines continue to proliferate across supply chains, threatening patients' health and safety, especially in low- and middle-income regions. This article discusses consequences and risks of antimicrobial resistance and other ways in which antimicrobial medicines can be of poor quality and recommends regulatory and policy reforms to help maintain supply chain resilience and quality of antimicrobial medicines. (Copyright 2024 American Medical Association. All Rights Reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|